Spiramycin (hexanedioate)
Based on 1 publication(s) in Google Scholar
Spiramycin hexanedioate (Rovamycin) is a macrolide antibiotic produced by Streptomyces ambofaciens with against bacteria and Toxoplasma gondii activities, and also has antiparasitic effect. Spiramycin hexanedioate is composed of a 16-member lactone ring, on which three sugars (mycaminose, forosamine, and mycarose) are attached.
For research use only. We do not sell to patients.
- CAS No.: 11034-40-5
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Spiramycin (hexanedioate)
MoreAll Parasite Isoforms
MoreAll Antibiotic Isoforms
More
Biological Activity
Description
IC50 & Target
|
Macrolide |
In Vitro
Spiramycin (24 hours; 1-1000 μM; T. gondii infected HeLa cells and HeLa cells) treatment reduces the cytotoxicity, and shows anti-Toxoplasma gondii activity, with IC50 values of 189 μM for HeLa cells; and 262 μM for T. gondii-infected HeLa cells[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:T. gondii infected HeLa cells and HeLa cells
-
Concentration:1-1000 μM
-
Incubation Time:24 hours
-
Result:Reduced the cytotoxicity.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:36 female KM mice with T.gondii[3]
-
Dosage:100 mg/kg
-
Administration:Intraperitoneal injection; every day; for 4 days
-
Result:The number of tachyzoites was significantly reduced. Reduced hepatotoxicity and significantly enhanced antioxidative effects. Granuloma and cyst formation were inhibitied.
Chemical Information
-
CAS No. 11034-40-5
-
SMILES
N/A
-
Synonyms
Rovamycin (hexanedioate)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Cell Prolif
Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin. [Abstract]2021 Jan;54(1):e12953. PMID: 33211371
Purity & Documentation
References
[1]. Nguyen HC, et al. Post-PKS tailoring steps of the spiramycin macrolactone ring in Streptomyces ambofaciens. Antimicrob Agents Chemother. 2013 Aug;57(8):3836-42. [Content Brief]
[2]. Etewa SE, et al. Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice. J Parasit Dis. 2018 Mar;42(1):102-113. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)